Prebiotics: A Novel Approach to Treat Hepatocellular CarcinomaReportar como inadecuado

Prebiotics: A Novel Approach to Treat Hepatocellular Carcinoma - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Canadian Journal of Gastroenterology and Hepatology - Volume 2017 2017, Article ID 6238106, 11 pages -

Review Article

Cell and Molecular Biology Lab, Department of Zoology, University of the Punjab, Q-A Campus, Lahore 54590, Pakistan

Cell and Applied Molecular Biology CAMB, University of the Punjab, Q-A Campus, Lahore 54590, Pakistan

Correspondence should be addressed to Nadeem Sheikh

Received 13 February 2017; Accepted 19 April 2017; Published 10 May 2017

Academic Editor: José L. Mauriz

Copyright © 2017 Naz Fatima et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Hepatocellular carcinoma is one of the fatal malignancies and is considered as the third leading cause of death. Mutations, genetic modifications, dietary aflatoxins, or impairments in the regulation of oncogenic pathways may bring about liver cancer. An effective barrier against hepatotoxins is offered by gut-liver axis as a change in gut permeability and expanded translocation of lipopolysaccharides triggers the activation of Toll-like receptors which stimulate the process of hepatocarcinogenesis. Prebiotics, nondigestible oligosaccharides, have a pivotal role to play when it comes to inducing an antitumor effect. A healthy gut flora balance is imperative to downregulation of inflammatory cytokines and reducing lipopolysaccharides induced endotoxemia, thus inducing the antitumor effect.

Autor: Naz Fatima, Tasleem Akhtar, and Nadeem Sheikh



Documentos relacionados